Skip to Main Content

Paper Details

Monitoring of Serum DNA Methylation as an Early Independent Marker of Response and Survival in Metastatic Breast Cancer: TBCRC 005 Prospective Biomarker Study.
J Clin Oncol
81
2017
MBC, Metastatic Breast Cancer, Patients, Serum, blood, breast cancer, cMethDNA, cell, circulating tumor cells, gene panel, genes, metastatic breast cancer, women
Author NameAffiliation
Lori J SokollJohns Hopkins University School of Medicine and Bloomberg School of Public Health MaryJo S. Fackler, Johns Hopkins University School of Medicine, Medical University of South Carolina, University of Alabama at Birmingham, Indiana University, University of Chicago, Dana-Farber Cancer Institute, University of North Carolina, Mayo Clinic
Elizabeth Garrett-MayerJohns Hopkins University School of Medicine and Bloomberg School of Public Health MaryJo S. Fackler, Johns Hopkins University School of Medicine, Medical University of South Carolina, University of Alabama at Birmingham, Indiana University, University of Chicago, Dana-Farber Cancer Institute, University of North Carolina, Mayo Clinic
Leslie CopeJohns Hopkins University School of Medicine and Bloomberg School of Public Health MaryJo S. Fackler, Johns Hopkins University School of Medicine, Medical University of South Carolina, University of Alabama at Birmingham, Indiana University, University of Chicago, Dana-Farber Cancer Institute, University of North Carolina, Mayo Clinic
Anna Maria StornioloJohns Hopkins University School of Medicine and Bloomberg School of Public Health MaryJo S. Fackler, Johns Hopkins University School of Medicine, Medical University of South Carolina, University of Alabama at Birmingham, Indiana University, University of Chicago, Dana-Farber Cancer Institute, University of North Carolina, Mayo Clinic
Rita NandaJohns Hopkins University School of Medicine and Bloomberg School of Public Health MaryJo S. Fackler, Johns Hopkins University School of Medicine, Medical University of South Carolina, University of Alabama at Birmingham, Indiana University, University of Chicago, Dana-Farber Cancer Institute, University of North Carolina, Mayo Clinic
Nancy U LinJohns Hopkins University School of Medicine and Bloomberg School of Public Health MaryJo S. Fackler, Johns Hopkins University School of Medicine, Medical University of South Carolina, University of Alabama at Birmingham, Indiana University, University of Chicago, Dana-Farber Cancer Institute, University of North Carolina, Mayo Clinic
Lisa A CareyJohns Hopkins University School of Medicine and Bloomberg School of Public Health MaryJo S. Fackler, Johns Hopkins University School of Medicine, Medical University of South Carolina, University of Alabama at Birmingham, Indiana University, University of Chicago, Dana-Farber Cancer Institute, University of North Carolina, Mayo Clinic
James N IngleJohns Hopkins University School of Medicine and Bloomberg School of Public Health MaryJo S. Fackler, Johns Hopkins University School of Medicine, Medical University of South Carolina, University of Alabama at Birmingham, Indiana University, University of Chicago, Dana-Farber Cancer Institute, University of North Carolina, Mayo Clinic
Antonio C WolffJohns Hopkins University School of Medicine and Bloomberg School of Public Health MaryJo S. Fackler, Johns Hopkins University School of Medicine, Medical University of South Carolina, University of Alabama at Birmingham, Indiana University, University of Chicago, Dana-Farber Cancer Institute, University of North Carolina, Mayo Clinic
  • 1 - 9

Datasets